Blog

Interview: CEO Erik Duhaime on Medical AI

Author Image
Laura Kier, VP of Growth
February 18, 2021
AI Med

— Via AIMed

The life-saving reason why medical annotation company Centaur Labs wants us all to start analyzing medical images

In 1987, Jack Treynor, Finance Professor at the University of Southern California, conducted an experiment with his class in an effort to prove market efficiency. Treynor asked each of his 56 students to estimate the number of jelly beans inside a jar. The jar contained 850 beans, and the median answer Treynor’s students gave was 870.

Only one student managed to give an estimate that was closer to the true value than the group median. The experiment became a classic example of the wisdom of crowds, where the average answer obtained from a group of individuals tends to be more accurate than the answers of the individuals themselves.

Erik Duhaime, Co-Founder and CEO of medical data labeling company Centaur.ai, knew the experiment. But when he studied it again during his PhD at the MIT Center for Collective Intelligence, he saw another potential use. At the center, researchers look at how humans and computers can be better connected to become more powerful.

“I was partly inspired by my wife, who was attending medical school and residency at that time,” says Duhaime. “My PhD research focused on how to aggregate the opinions of multiple experts. Particularly, overcoming the challenge of making the wisdom of crowds work for certain tasks like analyzing medical images, where some people might have the professional knowledge and skills to do so, while others do not.”

Read the full article at AIMed »

Related posts

May 9, 2025

Lung Nodule Segmentation Case Study | Ryver & Centaur AI

Centaur partnered with Ryver.ai to rigorously evaluate the accuracy of their synthetic lung nodule segmentations. Using our expert-led validation framework, we found Ryver’s synthetic annotations performed on par with human experts—highlighting synthetic data’s growing role in medical AI development.

Continue reading →
August 31, 2023

Erik Duhaime on GenAI in Healthcare | Emerj Interview

Erik Duhaime, CEO and Co-founder of Centaur.ai, discusses the impact of generative AI on healthcare and life sciences in an interview with Emerj.

Continue reading →
January 18, 2022

CB Insights Digital Health 150 Recognition | Centaur AI

Centaur.ai is recognized by CB Insights as a top global digital health startup

Continue reading →